Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age
Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervi...
Saved in:
Published in | Scientific reports Vol. 12; no. 1; pp. 16231 - 9 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
28.09.2022
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervical mucus could be an ancillary test for cervical neoplasms. The presence of miRNAs in 583 and 126 patients (validation and external cohorts) was determined by real-time RT-PCR. Performance of a combination with five miRNAs (miR-126-3p, -451a -144-3p, -20b-5p and -155-5p) was estimated by ROC curve analysis. Predicted probability (PP) was estimated by nomograms comprising -ΔCt values of the miRNAs, HPV genotype and age. A combination of five miRNAs showed a maximum AUC of 0.956 (95% CI: 0.933–0.980) for discriminating cancer. Low PP scores were associated with good prognosis over the 2-year observation period (
p
< 0.05). Accuracy for identifying cancer and cervical intraepithelial neoplasia (CIN) 3 + by nomogram was 0.983 and 0.966, respectively. PP was constant with different storage conditions of materials. We conclude that nomograms using miRNAs in mucus, HPV genotype and age could be useful as ancillary screening tests for cervical neoplasia. |
---|---|
AbstractList | Abstract Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervical mucus could be an ancillary test for cervical neoplasms. The presence of miRNAs in 583 and 126 patients (validation and external cohorts) was determined by real-time RT-PCR. Performance of a combination with five miRNAs (miR-126-3p, -451a -144-3p, -20b-5p and -155-5p) was estimated by ROC curve analysis. Predicted probability (PP) was estimated by nomograms comprising -ΔCt values of the miRNAs, HPV genotype and age. A combination of five miRNAs showed a maximum AUC of 0.956 (95% CI: 0.933–0.980) for discriminating cancer. Low PP scores were associated with good prognosis over the 2-year observation period (p < 0.05). Accuracy for identifying cancer and cervical intraepithelial neoplasia (CIN) 3 + by nomogram was 0.983 and 0.966, respectively. PP was constant with different storage conditions of materials. We conclude that nomograms using miRNAs in mucus, HPV genotype and age could be useful as ancillary screening tests for cervical neoplasia. Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervical mucus could be an ancillary test for cervical neoplasms. The presence of miRNAs in 583 and 126 patients (validation and external cohorts) was determined by real-time RT-PCR. Performance of a combination with five miRNAs (miR-126-3p, -451a -144-3p, -20b-5p and -155-5p) was estimated by ROC curve analysis. Predicted probability (PP) was estimated by nomograms comprising -ΔCt values of the miRNAs, HPV genotype and age. A combination of five miRNAs showed a maximum AUC of 0.956 (95% CI: 0.933–0.980) for discriminating cancer. Low PP scores were associated with good prognosis over the 2-year observation period (p < 0.05). Accuracy for identifying cancer and cervical intraepithelial neoplasia (CIN) 3 + by nomogram was 0.983 and 0.966, respectively. PP was constant with different storage conditions of materials. We conclude that nomograms using miRNAs in mucus, HPV genotype and age could be useful as ancillary screening tests for cervical neoplasia. Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervical mucus could be an ancillary test for cervical neoplasms. The presence of miRNAs in 583 and 126 patients (validation and external cohorts) was determined by real-time RT-PCR. Performance of a combination with five miRNAs (miR-126-3p, -451a -144-3p, -20b-5p and -155-5p) was estimated by ROC curve analysis. Predicted probability (PP) was estimated by nomograms comprising -ΔCt values of the miRNAs, HPV genotype and age. A combination of five miRNAs showed a maximum AUC of 0.956 (95% CI: 0.933–0.980) for discriminating cancer. Low PP scores were associated with good prognosis over the 2-year observation period ( p < 0.05). Accuracy for identifying cancer and cervical intraepithelial neoplasia (CIN) 3 + by nomogram was 0.983 and 0.966, respectively. PP was constant with different storage conditions of materials. We conclude that nomograms using miRNAs in mucus, HPV genotype and age could be useful as ancillary screening tests for cervical neoplasia. Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervical mucus could be an ancillary test for cervical neoplasms. The presence of miRNAs in 583 and 126 patients (validation and external cohorts) was determined by real-time RT-PCR. Performance of a combination with five miRNAs (miR-126-3p, -451a -144-3p, -20b-5p and -155-5p) was estimated by ROC curve analysis. Predicted probability (PP) was estimated by nomograms comprising -ΔCt values of the miRNAs, HPV genotype and age. A combination of five miRNAs showed a maximum AUC of 0.956 (95% CI: 0.933-0.980) for discriminating cancer. Low PP scores were associated with good prognosis over the 2-year observation period (p < 0.05). Accuracy for identifying cancer and cervical intraepithelial neoplasia (CIN) 3 + by nomogram was 0.983 and 0.966, respectively. PP was constant with different storage conditions of materials. We conclude that nomograms using miRNAs in mucus, HPV genotype and age could be useful as ancillary screening tests for cervical neoplasia.Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine whether aberrant expression of miRNAs in cervical mucus could be an ancillary test for cervical neoplasms. The presence of miRNAs in 583 and 126 patients (validation and external cohorts) was determined by real-time RT-PCR. Performance of a combination with five miRNAs (miR-126-3p, -451a -144-3p, -20b-5p and -155-5p) was estimated by ROC curve analysis. Predicted probability (PP) was estimated by nomograms comprising -ΔCt values of the miRNAs, HPV genotype and age. A combination of five miRNAs showed a maximum AUC of 0.956 (95% CI: 0.933-0.980) for discriminating cancer. Low PP scores were associated with good prognosis over the 2-year observation period (p < 0.05). Accuracy for identifying cancer and cervical intraepithelial neoplasia (CIN) 3 + by nomogram was 0.983 and 0.966, respectively. PP was constant with different storage conditions of materials. We conclude that nomograms using miRNAs in mucus, HPV genotype and age could be useful as ancillary screening tests for cervical neoplasia. |
ArticleNumber | 16231 |
Author | Iwata, Aya Nomura, Hiroyuki Kukimoto, Iwao Tsukamoto, Tetsuya Fujii, Takuma Mitani, Takeji Kotani, Kiriko Nishio, Eiji Ichikawa, Ryoko |
Author_xml | – sequence: 1 givenname: Kiriko surname: Kotani fullname: Kotani, Kiriko organization: Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University – sequence: 2 givenname: Aya surname: Iwata fullname: Iwata, Aya organization: Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University – sequence: 3 givenname: Iwao surname: Kukimoto fullname: Kukimoto, Iwao organization: Pathogen Genomics Center, National Institute of Infectious Diseases – sequence: 4 givenname: Eiji surname: Nishio fullname: Nishio, Eiji organization: Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University – sequence: 5 givenname: Takeji surname: Mitani fullname: Mitani, Takeji organization: Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University – sequence: 6 givenname: Tetsuya surname: Tsukamoto fullname: Tsukamoto, Tetsuya organization: Department of Pathology, School of Medicine, Fujita Health University – sequence: 7 givenname: Ryoko surname: Ichikawa fullname: Ichikawa, Ryoko organization: Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University – sequence: 8 givenname: Hiroyuki surname: Nomura fullname: Nomura, Hiroyuki organization: Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University – sequence: 9 givenname: Takuma surname: Fujii fullname: Fujii, Takuma email: fujiit44@fujita-hu.ac.jp organization: Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University |
BookMark | eNp9kk1v1DAQhiNUJErpH-BkiQsHAv6M7QtSVRVaqSoIAVfLcSbBq8Re7KTSnvnjOLtFpT3UB3tkv8_r8XheVkchBqiq1wS_J5ipD5kToVWNKa2JlmVmz6pjirmoKaP06L_4RXWa8waXIajmRB9Xf27iFIdkJ9THhLYJOu9m6EoUW9v60c87FHvkIN16Z0fkbCgxsqFDfs4r4JaUCzpC9jFktGQfBjT5bzdnyId7cFrckt-hy68_0QAhzrst7F3sAK-q570dM5zerSfVj08X388v6-svn6_Oz65rJxSba4Ipc40muMesd6zrOJeW95KAaBQtNQDe6baRUmrLHeWKqxY3DopKWio7dlJdHXy7aDdmm_xk085E681-I6bB2DR7N4IRPWG4EaWaSnPWiFaAFR00yjrSECWL18eD13ZpJ-gchDnZ8YHpw5Pgf5kh3hotiC75FoO3dwYp_l4gz2by2cE42gBxyYZKovn6cav0zSPpJi4plFKtKiUbzXVTVOqgcinmnKA3zs92Lp9S7vejIdis3WIO3WJKt5h9txhWUPoI_feOJyF2gHIRhwHSfVZPUH8ButbUSA |
CitedBy_id | crossref_primary_10_3390_ijms252413271 crossref_primary_10_7717_peerj_15912 crossref_primary_10_1111_cas_16214 |
Cites_doi | 10.1002/ijc.25630 10.1093/jnci/djn038 10.1093/jnci/djq356 10.1371/journal.pone.0227648 10.1097/pas.0000000000000986 10.1097/cej.0000000000000475 10.31557/apjcp.2021.22.4.1271 10.3892/ol.2020.12316 10.1002/1878-0261.12383 10.3390/ijms150915700 10.1111/cyt.12835 10.1245/s10434-015-4578-0 10.1080/15476286.2019.1582956 10.1158/0008-5472.can-04-0496 10.1002/14651858.CD008587.pub2 10.3892/ol.2019.10824 10.1038/s41598-021-89388-w 10.3322/caac.21660 10.1016/j.bbcan.2019.08.001 10.1155/2021/6650966 10.3390/jcm9113668 10.1038/s41416-019-0593-4 10.2174/1389202915666140528003249 10.1038/nrg3074 10.3390/molecules19021568 10.1093/jnci/dju241 10.1177/0004563217704233 10.1038/s41598-018-25310-1 10.1038/leu.2012.106 10.1002/ijc.29618 10.1038/s41598-020-79337-4 10.1093/nar/gkm952 10.1089/dna.2020.5590 10.1002/ijc.31855 10.1093/jjco/hyu112 10.1186/s12885-017-3642-5 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). |
Copyright_xml | – notice: The Author(s) 2022 – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). |
DBID | C6C AAYXX CITATION 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.1038/s41598-022-19722-3 |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_5f13065972894365b5ea5de68ac16187 PMC9519568 10_1038_s41598_022_19722_3 |
GrantInformation_xml | – fundername: JSPS – fundername: ; |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PUEGO Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c583t-1023c6910f03fc3dd447a4f71e5682415e4d9b67779a4c24848b06ce47a7a27d3 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Wed Aug 27 01:28:32 EDT 2025 Thu Aug 21 18:39:09 EDT 2025 Fri Jul 11 16:35:45 EDT 2025 Sat Aug 23 13:56:41 EDT 2025 Tue Jul 01 00:55:05 EDT 2025 Thu Apr 24 22:55:09 EDT 2025 Fri Feb 21 02:36:40 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c583t-1023c6910f03fc3dd447a4f71e5682415e4d9b67779a4c24848b06ce47a7a27d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-022-19722-3 |
PQID | 2718769496 |
PQPubID | 2041939 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5f13065972894365b5ea5de68ac16187 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9519568 proquest_miscellaneous_2719420458 proquest_journals_2718769496 crossref_citationtrail_10_1038_s41598_022_19722_3 crossref_primary_10_1038_s41598_022_19722_3 springer_journals_10_1038_s41598_022_19722_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-28 |
PublicationDateYYYYMMDD | 2022-09-28 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Grasedieck (CR32) 2012; 26 Snoek (CR27) 2019; 144 He (CR9) 2015 Berti (CR12) 2019; 1872 Coenen-Stass (CR29) 2019; 16 Matsumoto (CR23) 2011; 128 Matias-Garcia (CR31) 2020; 15 Causin (CR26) 2021; 2021 Sung (CR1) 2021; 71 Griffiths-Jones, Saini, van Dongen, Enright (CR7) 2008; 36 Kawai (CR15) 2018; 8 Lv, Tu, Huang, Lu, Xie (CR14) 2021; 21 Park (CR18) 2017; 17 Aftab (CR17) 2021; 11 Aiso, Takigami, Yamaki, Ohnishi (CR28) 2018; 55 Liu (CR22) 2020; 39 Andersen, Jensen, Ørntoft (CR34) 2004; 64 Tian (CR13) 2014; 106 Qi (CR25) 2020; 10 Sharma, Dua, Agarwal (CR8) 2014; 15 Pisarska, Baldy-Chudzik (CR11) 2020; 9 Ge (CR30) 2014; 19 Causin (CR35) 2019; 18 Kiviat, Hawes, Feng (CR2) 2008; 100 Stolnicu (CR20) 2018; 42 Bogani (CR21) 2019; 28 Esteller (CR6) 2011; 12 Kjaer, Frederiksen, Munk, Iftner (CR24) 2010; 102 Azimi, Paryan, Mondanizadeh, Sarmadian, Zamani (CR16) 2021; 22 Azuma (CR33) 2014; 44 Kelly (CR4) 2019; 121 Li (CR36) 2016; 23 Granados Lopez, Lopez (CR10) 2014; 15 Shiraz, Crawford, Egawa, Griffin, Doorbar (CR5) 2020; 31 Koliopoulos (CR3) 2017; 8 Liu (CR19) 2018; 12 H Sung (19722_CR1) 2021; 71 NB Kiviat (19722_CR2) 2008; 100 FCB Berti (19722_CR12) 2019; 1872 BC Snoek (19722_CR27) 2019; 144 S Kawai (19722_CR15) 2018; 8 PR Matias-Garcia (19722_CR31) 2020; 15 Y He (19722_CR9) 2015 Q Ge (19722_CR30) 2014; 19 S Grasedieck (19722_CR32) 2012; 26 S Griffiths-Jones (19722_CR7) 2008; 36 M Esteller (19722_CR6) 2011; 12 J Pisarska (19722_CR11) 2020; 9 S Stolnicu (19722_CR20) 2018; 42 G Bogani (19722_CR21) 2019; 28 J Liu (19722_CR22) 2020; 39 A Lv (19722_CR14) 2021; 21 M Aftab (19722_CR17) 2021; 11 RL Causin (19722_CR26) 2021; 2021 T Aiso (19722_CR28) 2018; 55 Y Azuma (19722_CR33) 2014; 44 SK Kjaer (19722_CR24) 2010; 102 H Kelly (19722_CR4) 2019; 121 SS Liu (19722_CR19) 2018; 12 AML Coenen-Stass (19722_CR29) 2019; 16 B Li (19722_CR36) 2016; 23 RL Causin (19722_CR35) 2019; 18 S Park (19722_CR18) 2017; 17 AJ Granados Lopez (19722_CR10) 2014; 15 G Sharma (19722_CR8) 2014; 15 K Matsumoto (19722_CR23) 2011; 128 CL Andersen (19722_CR34) 2004; 64 A Shiraz (19722_CR5) 2020; 31 G Koliopoulos (19722_CR3) 2017; 8 T Azimi (19722_CR16) 2021; 22 Y Qi (19722_CR25) 2020; 10 Q Tian (19722_CR13) 2014; 106 |
References_xml | – volume: 128 start-page: 2898 year: 2011 end-page: 2910 ident: CR23 article-title: Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study publication-title: Int. J. Cancer doi: 10.1002/ijc.25630 – volume: 100 start-page: 290 year: 2008 end-page: 291 ident: CR2 article-title: Screening for cervical cancer in the era of the HPV vaccine—the urgent need for both new screening guidelines and new biomarkers publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djn038 – volume: 102 start-page: 1478 year: 2010 end-page: 1488 ident: CR24 article-title: Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djq356 – volume: 15 start-page: e0227648 year: 2020 ident: CR31 article-title: Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples publication-title: PLoS ONE doi: 10.1371/journal.pone.0227648 – volume: 42 start-page: 214 year: 2018 end-page: 226 ident: CR20 article-title: International endocervical adenocarcinoma criteria and classification (IECC): A new pathogenetic classification for invasive adenocarcinomas of the endocervix publication-title: Am. J. Surg. Pathol. doi: 10.1097/pas.0000000000000986 – volume: 28 start-page: 435 year: 2019 end-page: 440 ident: CR21 article-title: Nomogram-based prediction of cervical dysplasia persistence/recurrence publication-title: Eur. J. Cancer Prev. doi: 10.1097/cej.0000000000000475 – volume: 22 start-page: 1271 year: 2021 end-page: 1277 ident: CR16 article-title: Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer publication-title: Asian Pac. J. Cancer Prev. doi: 10.31557/apjcp.2021.22.4.1271 – volume: 21 start-page: 54 year: 2021 ident: CR14 article-title: Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer publication-title: Oncol. Lett. doi: 10.3892/ol.2020.12316 – volume: 12 start-page: 2009 year: 2018 end-page: 2022 ident: CR19 article-title: Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer publication-title: Mol. Oncol. doi: 10.1002/1878-0261.12383 – volume: 15 start-page: 15700 year: 2014 end-page: 15733 ident: CR10 article-title: Multistep model of cervical cancer: participation of miRNAs and coding genes publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms150915700 – volume: 31 start-page: 258 year: 2020 end-page: 270 ident: CR5 article-title: The early detection of cervical cancer. The current and changing landscape of cervical disease detection publication-title: Cytopathology doi: 10.1111/cyt.12835 – volume: 23 start-page: 142 year: 2016 end-page: 148 ident: CR36 article-title: Incorporation of N0 stage with insufficient numbers of lymph nodes into N1 stage in the seventh edition of the TNM classification improves prediction of prognosis in gastric cancer: Results of a single-institution study of 1258 Chinese patients publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-015-4578-0 – volume: 16 start-page: 696 year: 2019 end-page: 706 ident: CR29 article-title: Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics publication-title: RNA Biol. doi: 10.1080/15476286.2019.1582956 – volume: 64 start-page: 5245 year: 2004 end-page: 5250 ident: CR34 article-title: Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets publication-title: Cancer Res. doi: 10.1158/0008-5472.can-04-0496 – volume: 8 start-page: Cd008587 year: 2017 ident: CR3 article-title: Cytology versus HPV testing for cervical cancer screening in the general population publication-title: Cochrane database syst. rev. doi: 10.1002/14651858.CD008587.pub2 – volume: 18 start-page: 4753 year: 2019 end-page: 4761 ident: CR35 article-title: Identification and performance evaluation of housekeeping genes for microRNA expression normalization by reverse transcription-quantitative PCR using liquid-based cervical cytology samples publication-title: Oncol. Lett. doi: 10.3892/ol.2019.10824 – volume: 11 start-page: 10323 year: 2021 ident: CR17 article-title: Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer publication-title: Sci. Rep. doi: 10.1038/s41598-021-89388-w – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: CR1 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 1872 start-page: 188306 year: 2019 ident: CR12 article-title: From squamous intraepithelial lesions to cervical cancer. Circulating microRNAs as potential biomarkers in cervical carcinogenesis publication-title: Biochim. Biophys. Acta Rev. cancer doi: 10.1016/j.bbcan.2019.08.001 – volume: 2021 start-page: 6650966 year: 2021 ident: CR26 article-title: MicroRNA biomarkers of high-grade cervical intraepithelial neoplasia in liquid biopsy publication-title: Biomed Res. Int. doi: 10.1155/2021/6650966 – volume: 9 start-page: 188306 year: 2020 ident: CR11 article-title: MicroRNA-Based Fingerprinting of Cervical Lesions and Cancer publication-title: J. Clin. Med. doi: 10.3390/jcm9113668 – volume: 121 start-page: 954 year: 2019 end-page: 965 ident: CR4 article-title: Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): A systematic review and meta-analysis publication-title: Br. J. Cancer doi: 10.1038/s41416-019-0593-4 – volume: 15 start-page: 310 year: 2014 end-page: 323 ident: CR8 article-title: A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer publication-title: Curr Genomics doi: 10.2174/1389202915666140528003249 – volume: 12 start-page: 861 year: 2011 end-page: 874 ident: CR6 article-title: Non-coding RNAs in human disease publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3074 – volume: 19 start-page: 1568 year: 2014 end-page: 1575 ident: CR30 article-title: miRNA in plasma exosome is stable under different storage conditions publication-title: Molecules doi: 10.3390/molecules19021568 – volume: 106 start-page: dju241 year: 2014 ident: CR13 article-title: MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/dju241 – volume: 55 start-page: 178 year: 2018 end-page: 180 ident: CR28 article-title: Degradation of serum microRNAs during transient storage of serum samples at 4 ℃ publication-title: Ann. Clin. Biochem. doi: 10.1177/0004563217704233 – volume: 8 start-page: 7070 year: 2018 ident: CR15 article-title: Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia publication-title: Sci. Rep. doi: 10.1038/s41598-018-25310-1 – volume: 26 start-page: 2414 year: 2012 end-page: 2416 ident: CR32 article-title: Impact of serum storage conditions on microRNA stability publication-title: Leukemia doi: 10.1038/leu.2012.106 – year: 2015 ident: CR9 article-title: A systematic study on dysregulated microRNAs in cervical cancer development publication-title: Int. J. Cancer doi: 10.1002/ijc.29618 – volume: 10 start-page: 22270 year: 2020 ident: CR25 article-title: Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach publication-title: Sci. Rep. doi: 10.1038/s41598-020-79337-4 – volume: 36 start-page: D154 year: 2008 end-page: 158 ident: CR7 article-title: miRBase: tools for microRNA genomics publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkm952 – volume: 39 start-page: 1328 year: 2020 end-page: 1346 ident: CR22 article-title: A microRNA-messenger rna regulatory network and its prognostic value in cervical cancer publication-title: DNA Cell Biol. doi: 10.1089/dna.2020.5590 – volume: 144 start-page: 372 year: 2019 end-page: 379 ident: CR27 article-title: Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer publication-title: Int. J. Cancer doi: 10.1002/ijc.31855 – volume: 44 start-page: 910 year: 2014 end-page: 917 ident: CR33 article-title: Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2/3 and invasive cervical cancer in Japanese women publication-title: Jpn. J. Clin. Oncol. doi: 10.1093/jjco/hyu112 – volume: 17 start-page: 658 year: 2017 ident: CR18 article-title: MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer publication-title: BMC Cancer doi: 10.1186/s12885-017-3642-5 – volume: 2021 start-page: 6650966 year: 2021 ident: 19722_CR26 publication-title: Biomed Res. Int. doi: 10.1155/2021/6650966 – volume: 9 start-page: 188306 year: 2020 ident: 19722_CR11 publication-title: J. Clin. Med. doi: 10.3390/jcm9113668 – volume: 23 start-page: 142 year: 2016 ident: 19722_CR36 publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-015-4578-0 – volume: 28 start-page: 435 year: 2019 ident: 19722_CR21 publication-title: Eur. J. Cancer Prev. doi: 10.1097/cej.0000000000000475 – volume: 31 start-page: 258 year: 2020 ident: 19722_CR5 publication-title: Cytopathology doi: 10.1111/cyt.12835 – volume: 55 start-page: 178 year: 2018 ident: 19722_CR28 publication-title: Ann. Clin. Biochem. doi: 10.1177/0004563217704233 – volume: 15 start-page: 15700 year: 2014 ident: 19722_CR10 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms150915700 – volume: 15 start-page: 310 year: 2014 ident: 19722_CR8 publication-title: Curr Genomics doi: 10.2174/1389202915666140528003249 – volume: 39 start-page: 1328 year: 2020 ident: 19722_CR22 publication-title: DNA Cell Biol. doi: 10.1089/dna.2020.5590 – volume: 8 start-page: Cd008587 year: 2017 ident: 19722_CR3 publication-title: Cochrane database syst. rev. doi: 10.1002/14651858.CD008587.pub2 – volume: 8 start-page: 7070 year: 2018 ident: 19722_CR15 publication-title: Sci. Rep. doi: 10.1038/s41598-018-25310-1 – volume: 19 start-page: 1568 year: 2014 ident: 19722_CR30 publication-title: Molecules doi: 10.3390/molecules19021568 – volume: 17 start-page: 658 year: 2017 ident: 19722_CR18 publication-title: BMC Cancer doi: 10.1186/s12885-017-3642-5 – volume: 71 start-page: 209 year: 2021 ident: 19722_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 22 start-page: 1271 year: 2021 ident: 19722_CR16 publication-title: Asian Pac. J. Cancer Prev. doi: 10.31557/apjcp.2021.22.4.1271 – volume: 18 start-page: 4753 year: 2019 ident: 19722_CR35 publication-title: Oncol. Lett. doi: 10.3892/ol.2019.10824 – volume: 100 start-page: 290 year: 2008 ident: 19722_CR2 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djn038 – volume: 42 start-page: 214 year: 2018 ident: 19722_CR20 publication-title: Am. J. Surg. Pathol. doi: 10.1097/pas.0000000000000986 – volume: 11 start-page: 10323 year: 2021 ident: 19722_CR17 publication-title: Sci. Rep. doi: 10.1038/s41598-021-89388-w – volume: 128 start-page: 2898 year: 2011 ident: 19722_CR23 publication-title: Int. J. Cancer doi: 10.1002/ijc.25630 – volume: 102 start-page: 1478 year: 2010 ident: 19722_CR24 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djq356 – volume: 106 start-page: dju241 year: 2014 ident: 19722_CR13 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/dju241 – year: 2015 ident: 19722_CR9 publication-title: Int. J. Cancer doi: 10.1002/ijc.29618 – volume: 21 start-page: 54 year: 2021 ident: 19722_CR14 publication-title: Oncol. Lett. doi: 10.3892/ol.2020.12316 – volume: 12 start-page: 2009 year: 2018 ident: 19722_CR19 publication-title: Mol. Oncol. doi: 10.1002/1878-0261.12383 – volume: 1872 start-page: 188306 year: 2019 ident: 19722_CR12 publication-title: Biochim. Biophys. Acta Rev. cancer doi: 10.1016/j.bbcan.2019.08.001 – volume: 36 start-page: D154 year: 2008 ident: 19722_CR7 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkm952 – volume: 16 start-page: 696 year: 2019 ident: 19722_CR29 publication-title: RNA Biol. doi: 10.1080/15476286.2019.1582956 – volume: 10 start-page: 22270 year: 2020 ident: 19722_CR25 publication-title: Sci. Rep. doi: 10.1038/s41598-020-79337-4 – volume: 44 start-page: 910 year: 2014 ident: 19722_CR33 publication-title: Jpn. J. Clin. Oncol. doi: 10.1093/jjco/hyu112 – volume: 64 start-page: 5245 year: 2004 ident: 19722_CR34 publication-title: Cancer Res. doi: 10.1158/0008-5472.can-04-0496 – volume: 144 start-page: 372 year: 2019 ident: 19722_CR27 publication-title: Int. J. Cancer doi: 10.1002/ijc.31855 – volume: 26 start-page: 2414 year: 2012 ident: 19722_CR32 publication-title: Leukemia doi: 10.1038/leu.2012.106 – volume: 12 start-page: 861 year: 2011 ident: 19722_CR6 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3074 – volume: 15 start-page: e0227648 year: 2020 ident: 19722_CR31 publication-title: PLoS ONE doi: 10.1371/journal.pone.0227648 – volume: 121 start-page: 954 year: 2019 ident: 19722_CR4 publication-title: Br. J. Cancer doi: 10.1038/s41416-019-0593-4 |
SSID | ssj0000529419 |
Score | 2.3919249 |
Snippet | Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their... Abstract Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques... |
SourceID | doaj pubmedcentral proquest crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 16231 |
SubjectTerms | 631/1647/2234 692/699/67/2322 Age Cervical cancer Cervix Cytology Genotype & phenotype Genotypes Human papillomavirus Humanities and Social Sciences miRNA Mucus multidisciplinary Nomograms Science Science (multidisciplinary) Storage conditions |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiKcILchI3GjUjePnsSCqFRIrhCjqzfIrsFI3W202h57548w42W1TCbhwjR-xPTOesWf8DSFvTQSqxiaVUcpYcuFE6VgDchVNrHRsvMvZGj4v5Pycf7oQF7dSfWFM2AAPPCzciWgqTG5uFEOkcCm8SE7EJLULiPWe35GDzrt1mBpQvZnhlRlfycxqfdKBpsLXZHD2wkxbrKwnmigD9k-szLsxknccpVn_nD0iD0fDkZ4OA35M7qX2Cbk_pJK8fkp-LdarHGlFwQqlVxv0v4AxSTFhzADFfU3XDQ15a4B-AlJ7Q10b6XLbYYPQg-29oZcJ7886igHxP-hq-XVxSpftTcNVH_rumM6_fKeI74pXuLkX2JeekfOzj98-zMsxwUIZhK63JcI2BAkGQzOrm1DHyLlyvFFVElKjak88Gi-VUsbxwLjm2s9kSFBLOaZi_ZwctOs2vSAwChnBtjIhVJ5Dp97rGa8998x5E5wpSLVbbBtG9HFMgnFpsxe81nYgkAUC2UwgWxfk3b7N1YC98dfa75GG-5qIm50_ADfZkZvsv7ipIEc7DrCjMHeWgf5W0nAjC_JmXwxiiL4V16Z1n-sYjtD-uiBqwjmTAU1L2uXPDOhtRH61WZDjHY_d_PzPE375PyZ8SB4wlAn0s-kjcrDd9OkVmFlb_zpL1G9yZSL3 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgCIkXxFUEBjISbyxakzi-PKGBmCokKoQY6pvlW0alNemS5mHP_HHOcdJWmcReG9t1e645x_4-Qj4oD1L1VUg95z5lpSlTk1dgV175TPrKmsjW8H3B5xfs27JcjgW3bjxWufOJ0VH7xmGN_DQHJyq4Yop_2lynyBqF3dWRQuM-eYDQZajVYin2NRbsYrFMjXdlZoU87SBe4Z0yeANDvq08LSbxKML2T3LN2yclb7VLYxQ6f0Iej-kjPRvk_ZTcC_Uz8nAglLx5Tv4umnU8b0UhF6WbFrswkFJSpI0ZALlvaFNRFx0ErONQ5i01taerbYcTXA8ZeEuvAlbROorH4i_pevVzcUZX9WHiund9d0LnP35TRHnFQm5cBbzTC3Jx_vXXl3k60iykrpTFNkXwBschbahmReUK7xkThlUiCyWXGOAD88pyIYQyzOVMMmln3AUYJUwufPGSHNVNHV4R2AX3kGEp5zLLYFFr5YwVltncWOWMSki2-7O1GzHIkQrjSsdeeCH1ICANAtJRQLpIyMf9nM2AwHHn6M8ow_1IRM-OHzTtpR6NUZcVRG4Or1I5os_z0pbBlD5waRzyB4iEHO80QI8m3emDAibk_f4xGCN2WEwdmj6OUQwB_mVCxERzJhuaPqlXfyKstyrj3c2EnOx07PDl___Br-_e6xvyKEdtxz6aPCZH27YPbyGN2tp30Vb-AWsNG-M priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF9qi-CL-ImxVVbwzQYvyX4-nmI5DjxErfQt7FfqgZeU3OWhz_7jndkkV1JU8DWZ2Wx2Zndmd2Z_Q8hb7UGqvgqpF8KnjBuemryCeeW1z5SvrInVGj6vxOKcLS_4xQHJx7swMWk_QlrGZXrMDnu_BUODl8Fg64SFsvK0uEeOEKoddPtoPl9-W-5PVjB2xTI93JCZFeoPzBMrFMH6Jx7m3fzIO0HSaHvOHpGHg9NI5303H5ODUD8h9_syktdPye9Vs4lZVhQ8UHrVYuwFHEmKxWJ6GO5r2lTUxWUB2nEo6Zaa2tP1bosMrgO_u6UwBKiFFJPhL-lm_XU1p-v6lnHTuW57ShdfflDEdsXj29gKrEnPyPnZp-8fF-lQXCF1XBW7FCEbnABnoZoVlSu8Z0waVskscKHQrAfmtRVSSm2Yy5liys6EC0AlTS598Zwc1k0dXhDohfDgV2nnMsugUWvVjBWW2dxY7YxOSDYOdukG5HEsgPGrjBHwQpW9gEoQUBkFVBYJebfnuepxN_5J_QFluKdEzOz4oGkvy0GHSl6BvRawgcoRc15wy4PhPghlHFYNkAk5GTWgHCbytszBdkuhmRYJebN_DVMQ4yqmDk0XaTRDWH-VEDnRnEmHpm_q9c8I5q15vLGZkNNRx24__vcffvl_5MfkQY7aj9E0dUIOd20XXoEztbOvh9lzAy6PGuo priority: 102 providerName: Springer Nature |
Title | Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age |
URI | https://link.springer.com/article/10.1038/s41598-022-19722-3 https://www.proquest.com/docview/2718769496 https://www.proquest.com/docview/2719420458 https://pubmed.ncbi.nlm.nih.gov/PMC9519568 https://doaj.org/article/5f13065972894365b5ea5de68ac16187 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEF7yoNBL6ZOqSc0WemvU2tJqH4dSHJNgDDEhrYtvYl9KDLacyDbU5_7xzqxkB4e0p54E2oceM7Mzu7P7fYR8VA6k6gofO85dzDKdxTopwK6cch3pCqMDW8PFkPdHbDDOxntkQ3fU_MDFo1M75JMaVdPPv-7W38Dgv9ZHxuWXBTghPCgG0yok0UridJ8cgmcSyGhw0YT7NdZ3olhHNWdnHm-6458CjP9O7Plw5-SD9GnwSufPybMmnKTdWv4vyJ4vX5InNcHk-hX5PZzPwv4rCrEpva0wKwMhJkUamRqge03nBbVhwIB-LOpARXXp6GS5wAZ2BRF5RaceV9UWFLfJX9PZ5GrYpZPyvuFsZVeLE9q__EkR9RUXdkMvMFq9JqPzsx-9ftzQLsQ2k-kyRjAHyyGMKNppYVPnGBOaFaLjMy7R4XvmlOFCCKWZTZhk0rS59VBL6ES49A05KOelf0vgLbiDiEtZ2zEMOjVGtllqmEm0UVariHQ2Pzu3DSY5UmNM85AbT2VeCygHAeVBQHkakU_bNrc1Isc_a5-iDLc1EU073JhX13ljnHlWgCfnMLVKEI2eZybzOnOeS22RT0BE5HijAflGQ_MEvLrgiikekQ_bYjBOzLjo0s9XoY5iCPgvIyJ2NGfnhXZLyslNgPlWWTjLGZGTjY7dP_zvH_zuf3zwEXmaoE1g9k0ek4NltfLvIfhamhbZF2PRIofd7uD7AK6nZ8PLK7jb471WWNBoBZv7A6ZKMSw |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIIXxFUEBhgJnli0NnF8eUBoXKaObRVCG-qbcWxnVFqT0rRCfeb_8Bs5x0ladRJ722tsnzg5V_vY5yPktXLAVVf42HHuYpaZLDZJAXrllOtLV-QmoDWcDPngjH0ZZaMt8re7C4PHKjubGAy1qyzuke8lYEQFV0zx99NfMaJGYXa1g9BoxOLIL3_Dkq1-d_gJ-PsmSQ4-n34cxC2qQGwzmc5jrFVgOXjJopcWNnWOMWFYIfo-4xL9mWdO5VwIoQyzCZNM5j1uPfQSJhEuBbo3yE1wvD1c7ImRWO3pYNaM9VV7N6eXyr0a6OEdNljxIb5XEqcb_i_ABGzEtpdPZl5Kzwavd3CP3G3DVbrfyNd9suXLB-RWA2C5fEj-DKtJON9FIfal0xlmfSCEpQhT0xQAX9KqoDYYJKBjUcZm1JSOjuc1DrALiPhn9MLjrl1N8Rj-OZ2Mvw336bhcD5ws7KLepYOv3ylWlcWN40AFrOEjcnYtDHhMtsuq9E8IzII7iOiUtf2cAdE8lz2W5ixPTK6sURHpdz9b27bmOUJvXOiQe0-lbhikgUE6MEinEXm7GjNtKn5c2fsD8nDVE6t1hwfV7Fy3yq-zAiIFDku3BKvd8yzPvMmc59JYxCsQEdnpJEC3JqTWa4GPyKtVMyg_ZnRM6atF6KMYAgrIiIgNydmY0GZLOf4ZyoirLNwVjchuJ2Prl___g59ePdeX5Pbg9ORYHx8Oj56ROwlKPubw5A7Zns8W_jmEcPP8RdAbSn5ct6L-A9NbVxY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJxAviE8RGGAkeGJR28Sx4weENrZqY1BVE0N7y_yVUWlNStMK9Zn_ir-OOydp1Unsba-xfXFy5_Od73w_Qt5JC1y1uQst5zZkiUpCFeWwrqy0_dTmWnm0hm9DfnTGvpwn51vkb3sXBtMqW53oFbUtDZ6RdyNQooJLJnk3b9IiRgeDT9NfISJIYaS1hdOoReTELX-D-1Z9PD4AXr-PosHh989HYYMwEJokjech1i0wHHbMvBfnJraWMaFYLvou4SnubY5ZqbkQQipmIpayVPe4cdBLqEjYGOjeIdsCvaIO2d4_HI5OVyc8GENjfdnc1OnFabcCinijDfw_RPuKwnhjN_SgARuW7vU8zWvBWr8HDh6SB43xSvdqaXtEtlzxmNyt4SyXT8ifYTnx2V4ULGE6nWEMCAxaiqA1dTnwJS1zarx6AjoGJW5GVWHpeF7hALMA-39Grxye4VUUk_Iv6WR8Otyj42I9cLIwi2qXHo1-UKwxi8fIngroxqfk7FZY8Ix0irJwzwnMgluw76Qxfc2AqNZpj8Wa6UhpaZQMSL_92ZlpKqAjEMdV5iPxcZrVDMqAQZlnUBYH5MNqzLSu_3Fj733k4aon1u72D8rZZdaogizJwW7g4MhFWPueJzpxKrGOp8ogeoEIyE4rAVmjUKpsLf4BebtqBlWA8R1VuHLh-0iG8AJpQMSG5GxMaLOlGP_0RcVl4m-OBmS3lbH1y___wS9unusbcg8Wafb1eHjyktyPUPAxoJfukM58tnCvwJ6b69fNwqHk4rbX6j_Palyx |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nomogram+for+predicted+probability+of+cervical+cancer+and+its+precursor+lesions+using+miRNA+in+cervical+mucus%2C+HPV+genotype+and+age&rft.jtitle=Scientific+reports&rft.au=Kiriko+Kotani&rft.au=Aya+Iwata&rft.au=Iwao+Kukimoto&rft.au=Eiji+Nishio&rft.date=2022-09-28&rft.pub=Nature+Portfolio&rft.eissn=2045-2322&rft.volume=12&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1038%2Fs41598-022-19722-3&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_5f13065972894365b5ea5de68ac16187 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |